Young Investigator Awards

IAPRD announces the 2024 Young Investigator Award Winners

First place winner: Chiara Pasquini (Pavia, Italy)

She is a Medical Graduate and Research Fellow at IRCCS Mondino Foundation in Pavia, Italy. She is interested in studying the genetic basis of Parkinson’s Disease, specifically GBA mutations, and their role in determining the pathological phenotype of Parkinson disease.

Second place winner: Justyna Korbecka (Wroclaw, Poland)

She is undergoing neurology training at the Department of Neurology, University Clinical Hospital in Wroclaw, Poland and is a PhD candidate at Wroclaw Medical University. Her research is focused on investigating alterations in the gut microbiota in patients diagnosed with Parkinson’s disease and their potential influence on clinical symptoms, aiming to uncover innovative adjunctive therapeutic strategies for the condition.

Third place winner: Gen Li (Shanghai, China)

He is from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. His area of study is the nonpharmacological treatment of Parkinson’s disease.

Best Oral Poster Presentation Awards

  • Daniela Pimenta Silva (Lisbon, Portugal) – O_06:
    Immersive virtual reality as a complement to physical therapy for Parkinson’s disease – A randomized controlled trial
  • Sirui Zhang (Chengdu, China) – O_16:
    Novel insights into the sex-specific role of lipid and apolipoprotein traits associated with risk of Parkinson’s disease: A prospective study
    Joaquim Ferreira (Torres Vedras, Portugal) – O_21:
    Opicapone as Add-on to Levodopa in Parkinson’s Patients without Motor Complications: Preliminary Data from EPSILON
  • Oscar Bernal-Pacheco (Bogotá, Colombia) – O_31:
    Deep Brain Stimulation of the Posterior Hypothalamus in Aggression Management – A Case Series Analysis
  • Ibrahem Hanafi (Würzburg, Germany) – O_32:
    Brain metabolic correlates of STN-DBS on gait in Parkinson’s disease: FDG-PET study of gait with dynamic obstacle avoidance
  • Zbigniew Wszolek (Jacksonville, United States) – O_33:
    Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
  • Fabrizio Stocchi (Rome, Italy) – O_43:
    Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless)
  • João Moura (Porto, Portugal) – O_55:
    The phenotypic spectra of polyQ expansion versus non-expansion forms in spinocerebellar ataxias

Best Guided Poster Tour Presentation Awards

  • José-Francisco Rocha (Coronado, Portugal) – P_08 (GPT):
    Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson’s Disease
  • Marcelo Mendonça (Lisbon, Portugal) – P_38 (GPT):
    Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease
  • Valtteri Syvänen (Kuopio, Finland) – P_66 (GPT):
    Gut changes as potential trigger for Parkinson’s disease
  • Hanshu Liu (Wuhan, China) – P_87 (GPT):
    Two parallel nigrostriatal subcircuits mediate arousal effect of dopaminergic neurons in substantia nigra pars compacta
  • Chad Heatwole (Rochester, United States) – P_104 (GPT):
    The PD-HI: Development and Validation of a Novel, Disease-Specific Patient-Reported Outcome Measure for Parkinson’s Disease Clinical Trials
  • Divyani Garg (New Delhi, India) – P_189 (GPT):
    Phospholipase-associated neurodegeneration in India: Observations from a case series of 20 patients
  • Pierfrancesco Mitrotti (Pavia, Italy) – P_214 (GPT):
    Intronic GAA-FGF14 Expansion in an italian patient presenting with early-onset cerebellar ataxia
  • Vesna Marija Van Midden (Ljubljana, Slovenia) – P_235 (GPT):
    Craniocervical synkinesias in movement disorder patients
  • Ana Jimena Hernández-Medrano (Mexico City, Mexico) – P_264 (GPT):
    Gender Disparities in Parkinson’s Disease: Exploring Quality of Life Among Mexican Men and Women (2011-2019)
  • Grace Liang (San Diego, United States) – P_286 (GPT):
    Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time

 

Latest news for the upcoming XXVI World Congress on Parkinson’s Diseease and Related Disorders:
The scheduled meeting for May 2021 will take place and update you on the latest developments and innovations in our field. Either we are looking forward to welcoming you at the brand new opened Maastricht Congress Center in person or our World Congress will take place online. In both scenarios a technical exhibition will be available and our sponsors are looking forward to (e)meeting you.

Stay updated and sign up for our newsletter. Looking forward seeing you in May 2021!